Russian scientists make rare find of 'blood' in mammoth
Russian scientists claimed Wednesday they have discovered blood in the carcass of a woolly mammoth, adding that the rare find could boost their chances of cloning the prehistoric animal.
Stereotyping prime obstacle to women in commercial science
Female professors are almost 50 percent less likely than their male counterparts to be invited to join corporate scientific advisory boards (SABs) and start new companies mainly because of gender stereotyping, says University ...
Samsung acquires US medical imaging company
South Korea's Samsung Electronics said Tuesday it had bought US medical imaging firm NeuroLogica, as it seeks to explore new growth sources by expanding into the health sector.
Graduate student invents new cancer drug delivery vehicle
(Phys.org)—Sean Hemp of Raleigh, N.C., a Ph.D. student in chemistry in the College of Science, is helping to invent new therapies that target genetic disease and cancer.
NGOs: Mexico risks corn damage if GM maize is planted
Environmentalists are warning that Mexico, the cradle of corn, risks damaging its staple if the government gives US firms the green light to plant genetically-modified maize in huge swaths of land.
Liquorice nanotech component offers clue to cleaner medical implants
A nanotech material containing an extract from liquorice can be used to sterilize and protect medical devices and implants which include biological components, and protects these functional bio-components during the sterilization ...
How better financing could help create new cancer drugs
The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no ...
Cuba launches first nanopharmaceutical
Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.
Bugs may be resistant to genetically modified corn
(AP) -- One of the nation's most widely planted crops - a genetically engineered corn plant that makes its own insecticide - may be losing its effectiveness because a major pest appears to be developing resistance ...
Vatican, biotech firm host adult stem cell meeting
(AP) -- The Vatican has entered into an unusual partnership with a small U.S. biotech company to promote using adult stem cells for treating disease, rather than focusing research on embryonic stem cells.
Europe's first human embryonic stem cell trial approved
A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.
The benefits of biotech: How GM crops benefit farmers and the developing world
The biotech industry boosted farming across the globe to the tune of almost $65 billion during the period 1996 to 2009, according to the latest analysis published in the International Journal of Biotechnology. $65 billio ...
Drugmakers brace for generic versions of biotech blockbusters
In 2001, Abbott Laboratories spent nearly $7 billion on the biggest acquisition in the company's 123-year history, primarily to access one drug, Humira.
The development of better biotech enzymes
Enzymes are proteins that speed up chemical reactions, such as laundry detergent digesting protein stains, which are otherwise very difficult to remove. A research team led by Professor Kam-bo Wong of the Centre for Protein ...